4/8
02:03 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/1
09:09 am
ogen
Oragenics, Inc. Files 10K and Provides Company Update [Yahoo! Finance]
Low
Report
Oragenics, Inc. Files 10K and Provides Company Update [Yahoo! Finance]
4/1
09:05 am
ogen
Oragenics, Inc. Files 10K and Provides Company Update
Low
Report
Oragenics, Inc. Files 10K and Provides Company Update
3/31
02:05 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Low
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/27
08:49 am
ogen
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity [Yahoo! Finance]
Neutral
Report
Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity [Yahoo! Finance]
3/23
02:04 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/18
07:09 am
ogen
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion [Yahoo! Finance]
Medium
Report
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion [Yahoo! Finance]
3/18
07:00 am
ogen
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
Medium
Report
Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
3/15
02:15 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
3/5
07:57 am
ogen
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion [Yahoo! Finance]
Medium
Report
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion [Yahoo! Finance]
3/5
07:45 am
ogen
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
Medium
Report
Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
3/1
04:12 pm
ogen
Oragenics Announces Closing of Public Offering [Yahoo! Finance]
Low
Report
Oragenics Announces Closing of Public Offering [Yahoo! Finance]
3/1
04:04 pm
ogen
Oragenics Announces Closing of Public Offering
Low
Report
Oragenics Announces Closing of Public Offering
2/28
06:58 am
ogen
Oragenics Shares Tumble Premarket After Stock Offering [MarketWatch]
Neutral
Report
Oragenics Shares Tumble Premarket After Stock Offering [MarketWatch]
2/28
02:02 am
ogen
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
High
Report
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
2/27
09:43 pm
ogen
Oragenics Announces Pricing of Public Offering [Yahoo! Finance]
High
Report
Oragenics Announces Pricing of Public Offering [Yahoo! Finance]
2/27
09:25 pm
ogen
Oragenics Announces Pricing of Public Offering
High
Report
Oragenics Announces Pricing of Public Offering
2/27
04:49 pm
ogen
Oragenics Announces Proposed Public Offering [Yahoo! Finance]
High
Report
Oragenics Announces Proposed Public Offering [Yahoo! Finance]
2/27
04:33 pm
ogen
Oragenics Announces Proposed Public Offering
High
Report
Oragenics Announces Proposed Public Offering
2/12
05:00 pm
ogen
Oragenics CEO Murphy Leaves, President Redmond Named Interim Replacement [MarketWatch]
High
Report
Oragenics CEO Murphy Leaves, President Redmond Named Interim Replacement [MarketWatch]
2/12
04:45 pm
ogen
Oragenics, Inc. Announces Leadership Transition [Yahoo! Finance]
High
Report
Oragenics, Inc. Announces Leadership Transition [Yahoo! Finance]
2/12
04:41 pm
ogen
Oragenics, Inc. Announces Leadership Transition
High
Report
Oragenics, Inc. Announces Leadership Transition
2/7
08:10 am
ogen
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement [Yahoo! Finance]
High
Report
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement [Yahoo! Finance]
2/7
08:00 am
ogen
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
High
Report
Oragenics, Inc. Announces Expiration of Its Investment Banking Engagement Agreement
2/5
08:12 am
ogen
Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion [Yahoo! Finance]
Medium
Report
Oragenics, Inc. Preparing for Phase II Clinical Trials to Treat Concussion [Yahoo! Finance]